Gene therapy as future treatment of erectile dysfunction

Bibliography

• Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6
   PubMed Web of Science ®Google Scholar
• McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000;12(Suppl 4):S6-11
   PubMed Web of Science ®Google Scholar
• Deng W, Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ. Gene and stem cell therapy for erectile dysfunction. Int J Impot Res 2005;17(Suppl 1):S57-63
   PubMedGoogle Scholar
• Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol 2003;169:1999-2007
   PubMed Web of Science ®Google Scholar
• Montorsi F, Briganti A, Salonia A, The ageing male and erectile dysfunction. BJU Int 2003;92:516-20
   PubMed Web of Science ®Google Scholar
• Johannes CB, Araujo AB, Feldman HA, Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460-3
   PubMed Web of Science ®Google Scholar
• Kloner RA. Erectile dysfunction in the cardiac patient. Curr Urol Rep 2003;4:466-71
   PubMedGoogle Scholar
• Kloner RA, Speakman M. Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep 2002;4:397-401
   PubMedGoogle Scholar
• Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep 2002;2:501-9
   PubMedGoogle Scholar
• Burnett AL. Strategies to promote recovery of cavernous nerve function after radical prostatectomy. World J Urol 2003;20:337-42
   PubMed Web of Science ®Google Scholar
• Rabbani F, Stapleton AM, Kattan MW, Factors predicting recovery of erections after radical prostatectomy. J Urol 2000;164:1929-34
   PubMed Web of Science ®Google Scholar
• Shimizu T, Hisasue S, Sato Y, Erectile dysfunction following nerve-sparing radical retropubic prostatectomy and its treatment with sildenafil. Int J Urol 2005;12:552-7
   PubMed Web of Science ®Google Scholar
• Siroky MB, Azadzoi KM. Vasculogenic erectile dysfunction: newer therapeutic strategies. J Urol 2003;170(2 Pt 2):S24-9; discussion S9-30
   PubMed Web of Science ®Google Scholar
• Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia 2001;44:1296-301
   PubMed Web of Science ®Google Scholar
• Briganti A, Salonia A, Deho F, Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. World J Urol 2005;23:374-84
   PubMed Web of Science ®Google Scholar
• Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999;281:421-6
   PubMed Web of Science ®Google Scholar
• Harraz A, Shindel AW, Lue TF. Emerging gene and stem cell therapies for the treatment of erectile dysfunction. Nat Rev Urol 2010;7:143-52
   PubMed Web of Science ®Google Scholar
• Rajfer J, Aronson WJ, Bush PA, Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90-4
   PubMed Web of Science ®Google Scholar
• Burnett AL, Lowenstein CJ, Bredt DS, Nitric oxide: a physiologic mediator of penile erection. Science 1992;257:401-3
   PubMed Web of Science ®Google Scholar
• Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther 2005;106:233-66
   PubMed Web of Science ®Google Scholar
• Feifer A, Carrier S. Pharmacotherapy for erectile dysfunction. Expert Opin Investig Drugs 2008;17:679-90
   PubMed Web of Science ®Google Scholar
• Hung A, Vernet D, Xie Y, Expression of inducible nitric oxide synthase in smooth muscle cells from rat penile corpora cavernosa. J Androl 1995;16:469-81
   PubMed Web of Science ®Google Scholar
• Saenz de Tejada I, Blanco R, Goldstein I, Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am J Physiol 1988;254:H459-67
   PubMed Web of Science ®Google Scholar
• Giuliano F, Rampin O. Neural control of erection. Physiol Behav 2004;83:189-201
   PubMed Web of Science ®Google Scholar
• Garban H, Vernet D, Freedman A, Effect of aging on nitric oxide-mediated penile erection in rats. Am J Physiol 1995;268:H467-75
   PubMed Web of Science ®Google Scholar
• Matz RL, Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 2003;20:527-50
   PubMed Web of Science ®Google Scholar
• Saenz de Tejada I, Goldstein I, Azadzoi K, Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-30
   PubMed Web of Science ®Google Scholar
• Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802-13
   PubMed Web of Science ®Google Scholar
• Champion HC, Bivalacqua TJ, Hyman AL, Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA 1999;96:11648-52
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Champion HC, Mehta YS, Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res 2000;12(Suppl 3):S8-17
   PubMedGoogle Scholar
• Bivalacqua TJ, Usta MF, Champion HC, Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003;169:1911-17
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Usta MF, Champion HC, Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res 2004;16:21-9
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Deng W, Kendirci M, Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol 2007;292:H1278-90
   PubMed Web of Science ®Google Scholar
• Magee TR, Ferrini M, Garban HJ, Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002;67:20-8
   PubMed Web of Science ®Google Scholar
• Garban H, Marquez D, Magee T, Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod 1997;56:954-63
   PubMed Web of Science ®Google Scholar
• Chancellor MB, Tirney S, Mattes CE, Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int 2003;91:691-6
   PubMed Web of Science ®Google Scholar
• Magee TR, Ferrini MG, Davila HH, Protein inhibitor of nitric oxide synthase (NOS) and the N-methyl-D-aspartate receptor are expressed in the rat and mouse penile nerves and colocalize with penile neuronal NOS. Biol Reprod 2003;68:478-88
   PubMed Web of Science ®Google Scholar
• Magee TR, Kovanecz I, Davila HH, Antisense and short hairpin RNA (shRNA) constructs targeting PIN (Protein Inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat. J Sex Med 2007;4:633-43
   PubMed Web of Science ®Google Scholar
• Kim NN, Cox JD, Baggio RF, Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry 2001;40:2678-88
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Hellstrom WJ. Potential application of gene therapy for the treatment of erectile dysfunction. J Androl 2001;22:183-90
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Burnett AL, Hellstrom WJ, Champion HC. Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol 2007;292:H1340-51
   PubMed Web of Science ®Google Scholar
• Hedlund P, Aszodi A, Pfeifer A, Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc Natl Acad Sci USA 2000;97:2349-54
   PubMed Web of Science ®Google Scholar
• Chang S, Hypolite JA, Velez M, Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol 2004;287:R950-60
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Kendirci M, Champion HC, Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha. BJU Int 2007;99:1488-94
   PubMed Web of Science ®Google Scholar
• Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999;161:5-11
   PubMed Web of Science ®Google Scholar
• Bemelmans BL, Meuleman EJ, Doesburg WH, Erectile dysfunction in diabetic men: the neurological factor revisited. J Urol 1994;151:884-9
   PubMed Web of Science ®Google Scholar
• Dahiya R, Chui R, Perinchery G, Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res 1999;11:201-6
   PubMed Web of Science ®Google Scholar
• Lin G, Chen KC, Hsieh PS, Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia. BJU Int 2003;92:631-5
   PubMed Web of Science ®Google Scholar
• Bennett NE, Kim JH, Wolfe DP, Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. J Urol 2005;173:1820-4
   PubMed Web of Science ®Google Scholar
• Talcott JA, Rieker P, Propert KJ, Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997;89:1117-23
   PubMed Web of Science ®Google Scholar
• Palma CA, Keast JR. Structural effects and potential changes in growth factor signalling in penis-projecting autonomic neurons after axotomy. BMC Neurosci 2006;7:41
   PubMedGoogle Scholar
• Laurikainen A, Hiltunen JO, Vanhatalo S, Glial cell line-derived neurotrophic factor is expressed in penis of adult rat and retrogradely transported in penile parasympathetic and sensory nerves. Cell Tissue Res 2000;302:321-9
   PubMed Web of Science ®Google Scholar
• Markus A, Patel TD, Snider WD. Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002;12:523-31
   PubMed Web of Science ®Google Scholar
• Wanigasekara Y, Keast JR. Neurturin has multiple neurotrophic effects on adult rat sacral parasympathetic ganglion neurons. Eur J Neurosci 2005;22:595-604
   PubMed Web of Science ®Google Scholar
• Laurikainen A, Hiltunen JO, Thomas-Crusells J, Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. J Neurobiol 2000;43:198-205
   PubMedGoogle Scholar
• Wanigasekara Y, Airaksinen MS, Heuckeroth RO, Neurturin signalling via GFRalpha2 is essential for innervation of glandular but not muscle targets of sacral parasympathetic ganglion neurons. Mol Cell Neurosci 2004;25:288-300
   PubMed Web of Science ®Google Scholar
• Hisasue S, Kato R, Suetomi T, Age-related alteration of neurturin receptor GFRa2 and nNOS in pelvic ganglia. Neurobiol Aging 2006;27:1524-30
   PubMed Web of Science ®Google Scholar
• Bella AJ, Fandel TM, Tantiwongse K, Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J Brachial Plex Peripher Nerve Inj 2007;2:5
   PubMedGoogle Scholar
• Kato R, Wolfe D, Coyle CH, Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther 2007;14:1344-52
   PubMed Web of Science ®Google Scholar
• Kato R, Wolfe D, Coyle CH, Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Ther 2009;16:26-33
   PubMed Web of Science ®Google Scholar
• Bakircioglu ME, Lin CS, Fan P, The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol 2001;165:2103-9
   PubMed Web of Science ®Google Scholar
• Gholami SS, Rogers R, Chang J, The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003;169:1577-81
   PubMed Web of Science ®Google Scholar
• Shirai M, Yamanaka M, Shiina H, Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun 2006;341:755-62
   PubMed Web of Science ®Google Scholar
• Yamanaka M, Shirai M, Shiina H, Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 2005;173:318-23
   PubMed Web of Science ®Google Scholar
• Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998;273:13313-16
   PubMed Web of Science ®Google Scholar
• Dall'Era JE, Meacham RB, Mills JN, Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model. Int J Impot Res 2008;20:307-14
   PubMed Web of Science ®Google Scholar
• Ryu JK, Cho CH, Shin HY, Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006;13:705-15
   PubMed Web of Science ®Google Scholar
• Rogers RS, Graziottin TM, Lin CS, Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003;15:26-37
   PubMed Web of Science ®Google Scholar
• Jung GW, Kwak JY, Yoon S, IGF-I and TGF-beta2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats. Int J Impot Res 1999;11:247-59
   PubMed Web of Science ®Google Scholar
• Bochinski D, Hsieh PS, Nunes L, Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res 2004;16:418-23
   PubMed Web of Science ®Google Scholar
• El-Sakka AI, Lin CS, Chui RM, Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res 1999;11:123-32
   PubMed Web of Science ®Google Scholar
• Pu XY, Hu LQ, Wang HP, Improvement in erectile dysfunction after insulin-like growth factor-1 gene therapy in diabetic rats. Asian J Androl 2007;9:83-91
   PubMed Web of Science ®Google Scholar
• Salkoff L, Butler A, Ferreira G, High-conductance potassium channels of the SLO family. Nat Rev Neurosci 2006;7:921-31
   PubMed Web of Science ®Google Scholar
• Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75:191-236
   PubMed Web of Science ®Google Scholar
• Wei AD, Gutman GA, Aldrich R, International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 2005;57:463-72
   PubMed Web of Science ®Google Scholar
• Spektor M, Rodriguez R, Rosenbaum RS, Potassium channels and human corporeal smooth muscle cell tone: further evidence of the physiological relevance of the Maxi-K channel subtype to the regulation of human corporeal smooth muscle tone in vitro. J Urol 2002;167:2628-35
   PubMed Web of Science ®Google Scholar
• Fan SF, Brink PR, Melman A, Christ GJ. An analysis of the Maxi-K+ (KCa) channel in cultured human corporal smooth muscle cells. J Urol 1995;153:818-25
   PubMed Web of Science ®Google Scholar
• Lau DH, Kommu SS, Siddiqui EJ, Gene therapy and erectile dysfunction: the current status. Asian J Androl 2007;9:8-15
   PubMed Web of Science ®Google Scholar
• Christ GJ, Rehman J, Day N, Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol 1998;275:H600-8
   PubMed Web of Science ®Google Scholar
• Christ GJ, Day N, Santizo C, Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004;287:H1544-53
   PubMed Web of Science ®Google Scholar
• Melman A, Zhao W, Davies KP, The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 2003;170:285-90
   PubMed Web of Science ®Google Scholar
• Melman A, Biggs G, Davies K, Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat. Gene Ther 2008;15:364-70
   PubMed Web of Science ®Google Scholar
• Christ GJ, Andersson KE, Williams K, Smooth-muscle-specific gene transfer with the human Maxi-K channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol 2009;52:1055-66
   Google Scholar
• Melman A, Bar-Chama N, McCullough A, hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum Gene Ther 2006;17:1165-76
   PubMed Web of Science ®Google Scholar
• Melman A, Bar-Chama N, McCullough A, Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a Phase I trial. Isr Med Assoc J 2007;9:143-6
   PubMed Web of Science ®Google Scholar
• Melman A, Rojas L, Christ G. Gene transfer for erectile dysfunction: will this novel therapy be accepted by urologists? Curr Opin Urol 2009;19:595-600
   PubMed Web of Science ®Google Scholar
• Venkateswarlu K, Giraldi A, Zhao W, Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers. J Urol 2002;168:355-61
   PubMed Web of Science ®Google Scholar
• So I, Chae MR, Lee SW. Gene transfer of the K(ATP) channel restores age-related erectile dysfunction in rats. BJU Int 2007;100:1154-60
   PubMed Web of Science ®Google Scholar
• Goins WF, Goss JR, Chancellor MB, Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Ther 2009;16:558-69
   PubMed Web of Science ®Google Scholar
• Gur S, Kadowitz PJ, Hellstrom WJ. A review of current progress in gene and stem cell therapy for erectile dysfunction. Expert Opin Biol Ther 2008;8:1521-38
   PubMed Web of Science ®Google Scholar
• Samaniego LA, Wu N, DeLuca NA. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol 1997;71:4614-25
   PubMed Web of Science ®Google Scholar
• Samaniego LA, Webb AL, DeLuca NA. Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol 1995;69:5705-15
   PubMed Web of Science ®Google Scholar
• Marconi P, Krisky D, Oligino T, Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci USA 1996;93:11319-20
   PubMed Web of Science ®Google Scholar
• Krisky DM, Marconi PC, Oligino T, Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 1997;4:1120-5
   PubMed Web of Science ®Google Scholar
• Jiang C, Wechuck JB, Goins WF, Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. J Virol 2004;78:8994-9006
   PubMed Web of Science ®Google Scholar
• Ozuer A, Wechuck JB, Goins WF, Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnol Bioeng 2002;77:685-92
   PubMed Web of Science ®Google Scholar
• Ozuer A, Wechuck JB, Russell B, Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnol Prog 2002;18:476-82
   PubMed Web of Science ®Google Scholar
• Wolfe D, Mata M, Fink DJ. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther 2009;16:455-60
   PubMed Web of Science ®Google Scholar
• Wolfe D, Wechuck J, Krisky D, A clinical trial of gene therapy for chronic pain. Pain Med 2009;10:1325-30
   PubMed Web of Science ®Google Scholar